Clinical Trials - Ataxia UK

Clinical Trials

VICO Therapeutics Clinical Trial updates

Spinocerebellar ataxias (SCAs) are a group of rare, progressive hereditary genetic disorders that affects the cerebellum, brain stem and spinal cord. Currently, more than 30 types of SCAs have been identified. SCAs are caused by genetic mutations, which lead to faulty […]

VICO Therapeutics Clinical Trial updates Read More »

Scroll to Top